Cargando…

Tracking the Epidemiologic Shifts in Hepatitis A Sero-Prevalence Using Age Stratification: A Cross-Sectional Study at Jordan University Hospital

The study of hepatitis A virus (HAV) epidemiology and sero-prevalence has important public health implications. Changes in the epidemiology of hepatitis A can result in a larger pool of susceptible persons in countries with improved sanitation and hygienic conditions if vaccination is not provided....

Descripción completa

Detalles Bibliográficos
Autores principales: Kareem, Nariman, Al-Salahat, Khaled, Bakri, Faris G., Rayyan, Yaser, Mahafzah, Azmi, Sallam, Malik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468970/
https://www.ncbi.nlm.nih.gov/pubmed/34578114
http://dx.doi.org/10.3390/pathogens10091081
_version_ 1784573809712431104
author Kareem, Nariman
Al-Salahat, Khaled
Bakri, Faris G.
Rayyan, Yaser
Mahafzah, Azmi
Sallam, Malik
author_facet Kareem, Nariman
Al-Salahat, Khaled
Bakri, Faris G.
Rayyan, Yaser
Mahafzah, Azmi
Sallam, Malik
author_sort Kareem, Nariman
collection PubMed
description The study of hepatitis A virus (HAV) epidemiology and sero-prevalence has important public health implications. Changes in the epidemiology of hepatitis A can result in a larger pool of susceptible persons in countries with improved sanitation and hygienic conditions if vaccination is not provided. The aim of this study was to investigate the prevalence of HAV immunoglobulin G (IgG) in Jordan. In addition, we aimed to identify the potential differences in HAV sero-prevalence based on age, among other variables. We recruited the study participants at Jordan University Hospital in Amman, Jordan, during October 2020–June 2021. Assessment of participants’ socio-demographic variables was done using a paper-based questionnaire. Testing for HAV IgG was based on a competitive enzyme linked immunosorbent assay (ELISA). The study population comprised 360 individuals with a median age of 18 years. The overall sero-prevalence of HAV in our study sample was 38.3%. Divided by age, the sero-prevalence of HAV was 8.2%, 12.3%, and 20.8% among individuals aged 10 years or less, 15 years or less, and 30 years or less, respectively. The estimated age at mid-population immunity was between 21 and 30 years. Besides age, individuals residing outside the Central region of Jordan had a significantly higher HAV sero-prevalence. Additionally, the use of filtered municipal water was associated with a lower sero-prevalence of HAV compared with the use of unfiltered municipal water among individuals aged 15 years or less. The results of this study suggest an intermediate to low endemicity of HAV in Jordan. An epidemiologic shift of HAV sero-prevalence with a declining rate of positivity for HAV IgG was noticed in this study. This highlights the importance of the recently introduced HAV vaccination in Jordan. Future research to evaluate the public health benefits of HAV vaccination in Jordan is recommended.
format Online
Article
Text
id pubmed-8468970
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84689702021-09-27 Tracking the Epidemiologic Shifts in Hepatitis A Sero-Prevalence Using Age Stratification: A Cross-Sectional Study at Jordan University Hospital Kareem, Nariman Al-Salahat, Khaled Bakri, Faris G. Rayyan, Yaser Mahafzah, Azmi Sallam, Malik Pathogens Article The study of hepatitis A virus (HAV) epidemiology and sero-prevalence has important public health implications. Changes in the epidemiology of hepatitis A can result in a larger pool of susceptible persons in countries with improved sanitation and hygienic conditions if vaccination is not provided. The aim of this study was to investigate the prevalence of HAV immunoglobulin G (IgG) in Jordan. In addition, we aimed to identify the potential differences in HAV sero-prevalence based on age, among other variables. We recruited the study participants at Jordan University Hospital in Amman, Jordan, during October 2020–June 2021. Assessment of participants’ socio-demographic variables was done using a paper-based questionnaire. Testing for HAV IgG was based on a competitive enzyme linked immunosorbent assay (ELISA). The study population comprised 360 individuals with a median age of 18 years. The overall sero-prevalence of HAV in our study sample was 38.3%. Divided by age, the sero-prevalence of HAV was 8.2%, 12.3%, and 20.8% among individuals aged 10 years or less, 15 years or less, and 30 years or less, respectively. The estimated age at mid-population immunity was between 21 and 30 years. Besides age, individuals residing outside the Central region of Jordan had a significantly higher HAV sero-prevalence. Additionally, the use of filtered municipal water was associated with a lower sero-prevalence of HAV compared with the use of unfiltered municipal water among individuals aged 15 years or less. The results of this study suggest an intermediate to low endemicity of HAV in Jordan. An epidemiologic shift of HAV sero-prevalence with a declining rate of positivity for HAV IgG was noticed in this study. This highlights the importance of the recently introduced HAV vaccination in Jordan. Future research to evaluate the public health benefits of HAV vaccination in Jordan is recommended. MDPI 2021-08-26 /pmc/articles/PMC8468970/ /pubmed/34578114 http://dx.doi.org/10.3390/pathogens10091081 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kareem, Nariman
Al-Salahat, Khaled
Bakri, Faris G.
Rayyan, Yaser
Mahafzah, Azmi
Sallam, Malik
Tracking the Epidemiologic Shifts in Hepatitis A Sero-Prevalence Using Age Stratification: A Cross-Sectional Study at Jordan University Hospital
title Tracking the Epidemiologic Shifts in Hepatitis A Sero-Prevalence Using Age Stratification: A Cross-Sectional Study at Jordan University Hospital
title_full Tracking the Epidemiologic Shifts in Hepatitis A Sero-Prevalence Using Age Stratification: A Cross-Sectional Study at Jordan University Hospital
title_fullStr Tracking the Epidemiologic Shifts in Hepatitis A Sero-Prevalence Using Age Stratification: A Cross-Sectional Study at Jordan University Hospital
title_full_unstemmed Tracking the Epidemiologic Shifts in Hepatitis A Sero-Prevalence Using Age Stratification: A Cross-Sectional Study at Jordan University Hospital
title_short Tracking the Epidemiologic Shifts in Hepatitis A Sero-Prevalence Using Age Stratification: A Cross-Sectional Study at Jordan University Hospital
title_sort tracking the epidemiologic shifts in hepatitis a sero-prevalence using age stratification: a cross-sectional study at jordan university hospital
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468970/
https://www.ncbi.nlm.nih.gov/pubmed/34578114
http://dx.doi.org/10.3390/pathogens10091081
work_keys_str_mv AT kareemnariman trackingtheepidemiologicshiftsinhepatitisaseroprevalenceusingagestratificationacrosssectionalstudyatjordanuniversityhospital
AT alsalahatkhaled trackingtheepidemiologicshiftsinhepatitisaseroprevalenceusingagestratificationacrosssectionalstudyatjordanuniversityhospital
AT bakrifarisg trackingtheepidemiologicshiftsinhepatitisaseroprevalenceusingagestratificationacrosssectionalstudyatjordanuniversityhospital
AT rayyanyaser trackingtheepidemiologicshiftsinhepatitisaseroprevalenceusingagestratificationacrosssectionalstudyatjordanuniversityhospital
AT mahafzahazmi trackingtheepidemiologicshiftsinhepatitisaseroprevalenceusingagestratificationacrosssectionalstudyatjordanuniversityhospital
AT sallammalik trackingtheepidemiologicshiftsinhepatitisaseroprevalenceusingagestratificationacrosssectionalstudyatjordanuniversityhospital